5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | NEUTRAL | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 21.17▼ | 21.09▼ | 21.06▼ | 20.99▲ | 18.92▲ |
MA10 | 21.17▼ | 21.07▼ | 21.14▼ | 20.51▲ | 19.96▲ |
MA20 | 21.15▼ | 21.09▼ | 21.06▼ | 18.95▲ | 23.27▼ |
MA50 | 21.07▼ | 20.93▲ | 20.92▲ | 20.47▲ | 23.93▼ |
MA100 | 21.08▼ | 20.84▲ | 19.66▲ | 23.69▼ | N/A |
MA200 | 20.97▲ | 19.44▲ | 18.75▲ | 24.94▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.010▼ | -0.010▼ | -0.030▼ | 0.444▲ | -0.484▼ |
RSI | 41.450▼ | 49.004▼ | 51.312▲ | 59.448▲ | 45.261▼ |
STOCH | 41.697 | 66.370 | 66.172 | 86.067▲ | 28.233 |
WILL %R | -100.000▼ | -38.806 | -28.659 | -10.254▲ | -60.604 |
CCI | -144.779▼ | 56.480 | 24.654 | 64.969 | -28.261 |
Wednesday, April 30, 2025 10:00 PM
ArriVent BioPharma, Inc. (Nasdaq: AVBP) has announced the appointment of Merdad Parsey, M.D., Ph.D., to its Board of Directors. A respected leader in global clinical development, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 21.06 | 21.31 | 20.335 | 21.08 | 124,300 |
30/04/25 | 20.48 | 21.60 | 19.48 | 21.26 | 183,700 |
29/04/25 | 20.635 | 21.165 | 20.635 | 20.86 | 78,261 |
28/04/25 | 20.94 | 21.05 | 20.16 | 20.92 | 165,400 |
25/04/25 | 20.80 | 21.00 | 20.41 | 20.82 | 153,390 |
24/04/25 | 21.08 | 21.24 | 20.49 | 21.17 | 108,200 |
23/04/25 | 20.82 | 21.625 | 20.58 | 21.08 | 247,000 |
22/04/25 | 19.81 | 20.59 | 19.65 | 20.28 | 148,400 |
21/04/25 | 17.86 | 19.69 | 17.43 | 19.54 | 202,600 |
17/04/25 | 17.37 | 18.42 | 17.37 | 18.14 | 167,338 |
|
|
||||
|
|
||||
|
|